EFIKASI ANTI IL-6 RECEPTOR MONOCLONAL ANTIBODY SEBAGAI TERAPI ADJUVAN PASIEN COVID-19 DENGAN CYTOKINE RELEASE SYNDROME: Sebuah Tinjauan Sistematis
Introduction: Cytokine release syndrome (CRS) take an important role in the progression of acute respiratory distress syndrome or multi-organ damage in severe COVID-19 patients. Several studies stated interleukin 6 including the main cytokine in the occurrence of CRS. We are interested in assessing...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
2022-01-14.
|
| Subjects: | |
| Online Access: | Link Metadata |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|